Summit Therapeutics Inc. (NASDAQ:SMMT) is one of the best hot stocks to buy according to Wall Street analysts. On July 3, ...

Summit Therapeutics (NASDAQ:SMMT) shares spiked on Thursday, triggering a trading halt after Bloomberg News reported that ...

Summit Therapeutics jumps 9% as AZN eyes a potential $15 billion licensing deal for its cancer drug, ivonescimab.

Revolution Medicines Inc. (NASDAQ:RVMD) is one of the best high short interest stocks with huge upside potential. On June 30, ...

Shares of Summit Therapeutics (NASDAQ:SMMT) jumped 5% on Thursday following reports that the company is in advanced ...

Especially high volume was seen for the $25 strike call option expiring July 18, 2025, with 1,411 contracts trading so far today, representing approximately 141,100 underlying shares of SMMT.

Summit Therapeutics Inc. (NASDAQ:SMMT) ranks among the 30 stocks expected to beat the market by 20 percentage points this ...

On June 2, the firm reaffirmed its Buy rating and maintained a $44 price target, more than double the current $18.21 share ...

In trading on Tuesday, shares of Summit Therapeutics Inc (Symbol: SMMT) crossed above their 200 day moving average of $20.88, changing hands as high as $21.82 per share. Summit Therapeutics Inc ...

The latest price target for Summit Therapeutics (NASDAQ:SMMT) was reported by UBS on July 1, 2025. The analyst firm set a price target for $30.00 expecting SMMT to rise to within 12 months (a ...